Alentemol (INN) (developmental code name U-66444B), or alentamol, is a selective dopamine autoreceptor agonist described as an antipsychotic, which was never marketed.

See also Lysergamides § Simplified or partial lysergamides LY-178210 Bay R 1531 (LY-197206) LY-293284

References